COMMUNIQUÉS West-GlobeNewswire

PCI Biotech: Publication of prospectus summary for transfer of listing to Oslo Børs
25/04/2018
Oslo (Norway), 25 th April 2018 - Reference is made to the stock exchange announcement made on 25 April 2018 regarding PCI Biotech Holding ASA ("PCI Biotech" or the "Company") being approved for listing on Oslo Børs as [...]
Financial calendar 2019
25/04/2018
Read the full announcement in the attached file Attachment 2018_17_Financial_calendar_EN
Natus Medical Announces First Quarter Financial Results
25/04/2018
Reports record first quarter revenue of $128.6 million Reports first quarter GAAP loss per share of $0.10 and non-GAAP earnings per share of $0.24 PLEASANTON, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Natus Medical [...]
Integra LifeSciences Reports First Quarter 2018 Financial Results
25/04/2018
Revenue Increased 38.1% to $357.1 million; Organic Revenue Increased 3.0% Reported EPS of $0.14; Adjusted EPS of $0.58 Company Raises Full-Year Total Revenue and EPS Guidance PLAINSBORO, N.J., April 25, 2018 (GLOBE [...]
INSYS Therapeutics to Report First Quarter 2018 Results on May 8
25/04/2018
PHOENIX, April 25, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]
HealthLynked Corp. Announces Expansion of Its Sales Team into New Key Markets
25/04/2018
NAPLES, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK), improving healthcare through its advanced personal health record and patient engagement platform, today announced the expansion of its [...]
Notice of annual general meeting in Xbrane Biopharma AB
25/04/2018
The shareholders of Xbrane Biopharma AB, reg. no. 556749-2375, (the " Company "), are hereby convened to the annual general meeting to be held on Thursday 24 May 2018, at 17.30 p.m. at Baker McKenzie's preemies at [...]
Shire plc : Shire announces revised proposal and extension of PUSU deadline to 8 May 2018
25/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]
Shire plc : Rule 2.9 Announcement
25/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 25 April 2018 [...]
Interim report for the first three months of 2018
25/04/2018
Read the full announcement in the attached file Attachment 2018_16_Q12018_CompanyAnnouncement_FINAL_EN
Nicox : Ouverture d'un bureau de développement aux Etats-Unis, à Research Triangle Park en Caroline du Nord
25/04/2018
Communiqué de presse Nicox : Ouverture d'un bureau de développement aux Etats-Unis, à Research Triangle Park en Caroline du Nord Les activités de développement de Nicox, en croissance aux Etats-Unis, sont transférées [...]
Nicox: :Opening of U.S. Development Office in Research Triangle Park, North Carolina
25/04/2018
Press Release Nicox: Opening of U.S. Development Office in Research Triangle Park, North Carolina Company to relocate its growing U.S. development operations to the North Carolina biotech hub in Research Triangle Park [...]
Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home
25/04/2018
FocalView is a first-of-its-kind app designed to modernize ophthalmic clinical trials, making them more accessible and flexible Using patients' self-recorded measurements, FocalView aims to enable more sensitive trial [...]
Targovax presentation at ChinaBio Partnering Forum 2018
25/04/2018
Oslo, Norway, 25 April 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumours, have today presented at the ChinaBio Partnering Forum 2018. [...]
Bone Therapeutics SA : Reports Full Year 2017 Results
25/04/2018
Regulated information Bone Therapeutics Reports Full Year 2017 Results Strong clinical progress in ALLOB ® spinal fusion and delayed union trials Leadership team strengthened with appointments of Jean Stéphenne as [...]
Bone Therapeutics SA : Publie ses résultats annuels 2017
25/04/2018
Information réglementée Bone Therapeutics publie ses résultats annuels 2017 Progrès cliniques importants avec ALLOB ® dans la fusion vertébrale et dans les fractures avec retard de consolidation Renforcement de l'équipe [...]
Shire plc : Shire announces revised proposal and extension of PUSU deadline to 8 May 2018
25/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]
Compass Cannabis Closes Over-Subscribed Non-Brokered Financing
24/04/2018
CALGARY, Alberta, April 24, 2018 (GLOBE NEWSWIRE) -- 10330698 Canada Ltd. (dba Compass Cannabis Clinic, or “the Company”) is a medical cannabis consultation company with thirty nine clinics that are now open or signed [...]
Psychemedics Announces 1Q Record Revenues and Dividend Increase of 20%
24/04/2018
ACTON, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD ) today announced first quarter financial results for the period ended March 31, 2018. The Company also announced a quarterly [...]

Pages